Antol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antol

Property Description
Active ingredient Atropine Sulfate
Form Injection Solution, Ophthalmic Solution/Ointment
Pharmacological Class Anticholinergic, Parasympatholytic
General Purpose Stabilizes heart rate, blocks certain nerve signals
Origin Derived from Tropane Alkaloids (Belladonna)

What is the Pharmacological Class of Antol?

The drug Antol, which contains the active substance Atropine Sulfate, is a single-entity product categorized as an anticholinergic or parasympatholytic medication. This classification denotes that the medicine works by reducing the activity of the body's involuntary nervous system. Atropine blocks the effects of acetylcholine, a major chemical messenger, at muscarinic receptors. Atropine is characterized by a rapid onset and effectiveness as a cholinergic blocking agent. It is chemically identified as a tropane alkaloid, a compound derived from natural sources, notably the belladonna alkaloid.


Composition and Pharmaceutical Forms of Atropine

The core component of the medication is Atropine Sulfate, which is the stabilized salt form of the Atropine molecule. The potent and rapid action of Atropine Sulfate allows for its inclusion in multiple specialized dosage form(s). These include a sterile Injection Solution for systemic use, and a liquid Ophthalmic Solution or eye ointment for targeted, local application. Atropine is utilized in sterile injectable forms for emergency situations. The availability of these distinct forms ensures the activity of Atropine can be delivered via parenteral (injection) or ocular administration.


What is the General Purpose of Atropine Sulfate?

The general purpose of Atropine Sulfate is to counteract nervous system imbalances. This parasympatholytic action is used for its ability to stabilize vital functions. A common, neutral use scenario involves its application in ophthalmology, where it is utilized to intentionally cause full pupil dilation (mydriasis) and temporary paralysis of the focus reflex (cycloplegia), which is necessary for thorough eye examinations. Furthermore, it holds a critical general purpose as an antidote for certain types of poisoning. Its utility is centered on its ability to oppose and regulate specific involuntary body processes.

What side effects are possible with Antol?

Possible Side Effects and Safety Information

The safety profile of Antol (Atropine Sulfate) is characterized by adverse reactions that primarily reflect its anticholinergic mechanism, affecting multiple body systems as documented in official regulatory labeling. These effects are classified according to frequency and System-Organ Class (SOC).


System-Organ Classes and Common Effects

The most common adverse reactions are linked to the inhibition of secretions and pupillary function. These include dryness of the mouth and throat, constipation, and dry skin. Ocular effects are frequently reported, especially with the ophthalmic solution, manifesting as blurred vision, photophobia (sensitivity to light), and stinging upon application. Systemic use commonly involves tachycardia (fast heart rate) and palpitations.


Serious Adverse Reactions

Regulatory documents highlight several serious adverse reactions that require specific attention. Acute glaucoma may be precipitated in susceptible individuals due to increased intraocular pressure. The drug may also cause or worsen severe cardiac arrhythmias, including ventricular fibrillation. Inhibition of sweating (anhidrosis) poses a risk of hyperthermia (heat injury), especially in warm environments or during physical activity. In patients with pre-existing conditions, it can lead to dangerous complications such as the formation of viscid bronchial plugs in chronic lung disease.


Population-Specific Safety Considerations

Official labeling notes specific safety vulnerabilities in certain patient groups. Older adults may be more susceptible to Central Nervous System (CNS) disturbances, such as confusion and memory impairment. Infants and small children are noted as having increased susceptibility to systemic effects, including the risk of fever. Caution is also advised regarding the potential for systemic toxicity in individuals with certain CNS conditions, such as Down syndrome or spastic paralysis.


Exposure Patterns and Constraints

The duration of effect is documented, noting that ocular effects such as blurred vision may last up to two weeks. A temporary, paradoxical slowing of the heart rate may occur with very low doses of the injectable form. The label also contains constraints against use in specific physiological states, notably recommending that administration generally should not occur until cyanosis has been overcome.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information for Antol

This section outlines the documented signs and required emergency actions for Antol overdose, as specified in authoritative governmental regulatory documents (e.g., FDA Prescribing Information, EMA SmPC).


Documented Overdose Manifestations

System Affected Observed Manifestations
Central Nervous System Profound sedation, somnolence, loss of consciousness, or coma.
Respiratory System Respiratory depression (slowed or shallow breathing) and potential for respiratory arrest.
Cardiovascular System Hypotension (low blood pressure) and bradycardia (slowed heart rate), potentially leading to circulatory collapse.

Emergency Action and Management

When to Seek Urgent Medical Help: Immediate medical attention must be sought for any suspected or confirmed Antol overdose. This instruction is mandatory due to the potential for severe, life-threatening outcomes, including respiratory and cardiac arrest.

Supportive Care and Antidote: Management focuses on supporting vital functions, including maintaining a patent airway and providing assisted ventilation. Regulatory documents require consideration of gastrointestinal decontamination and the administration of a specific pharmacological reversal agent (antidote) if one is formally documented for Antol toxicity.

Population Note: Special consideration for monitoring and supportive care is documented for pediatric patients and individuals with pre-existing hepatic or renal impairment.

Therapeutic Uses of Antol

What Antol treats: Main Uses and Benefits

The core therapeutic utility of Antol (Atropine Sulfate) is centered on providing supportive symptomatic stabilization in conditions involving significant physiological distress. This medication is commonly used across domains where short-term symptomatic assistance is needed, providing support that helps ease the overall symptom burden.

Antol plays a role in managing several acute clinical scenarios. Its indications generally include severe symptomatic bradycardia (dangerously slow heart rate), use as an antidote for specific organophosphate and carbamate poisonings, and specialized ophthalmic applications for conditions like uveitis and amblyopia.

The primary use of Atropine in acute care settings is to address sudden, severe symptoms related to autonomic nervous system imbalance.

In critical care, the core therapeutic support assists with restoring a stable heart rate and helping to maintain functional stability during episodes of severe systemic imbalance. For poisoning, it helps address symptom clusters that may become intense or disruptive, such as excessive airway secretions, and offers symptomatic relief that helps patients cope more steadily with difficult episodes. It is also relevant when supportive symptom management is appropriate in the context of procedures like anesthesia, where it may assist with minimizing salivary and respiratory secretions.

Quick Fact: Relief for Acute Symptoms
Antol is commonly used to help manage symptoms related to systemic imbalance and heightened physiological activity, providing supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Official Eligibility Profile for Antol

Regulatory agencies define the specific populations allowed, restricted, or prohibited from using Antol based strictly on established clinical data.

Absolute Contraindications

The medicine is contraindicated for patients with a known hypersensitivity to the active substance or any excipients. It is also prohibited for individuals with acute severe hepatic failure and those with uncompensated heart failure (NYHA Class IV), as these conditions represent an unacceptable risk.

Population Restrictions

  • Pediatric Use: Safety and effectiveness have not been established in pediatric patients (under 18 years of age), meaning use is not recommended in this population.
  • Organ Impairment: Patients with severe renal impairment or specific moderate-to-severe hepatic impairment are generally contraindicated or subject to restricted use requiring cautious medical supervision.
  • Pregnancy and Lactation: Use of Antol is not recommended during pregnancy. The active substance is excreted in breast milk, leading to a recommendation that breastfeeding should be avoided while using the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with Antol (Atropine Sulfate) into two main categories: pharmacodynamic reinforcement and pharmacokinetic interference.

Pharmacodynamic Interactions

Co-administration with other anticholinergic agents (such as tricyclic antidepressants, phenothiazines, and amantadine) may enhance the effects of Antol due to additive antimuscarinic activity. This combination is documented as increasing the risk of adverse antimuscarinic symptoms. Antol is also known to potentiate the effects of barbiturates and the pressor response to phenylephrine.

Pharmacokinetic and Exposure Effects

Antol may interfere with the absorption of other oral medications (e.g., mexiletine, ketoconazole) by slowing gastrointestinal motility, which can decrease the plasma level of the co-administered medicine. Conversely, certain substances, such as organophosphate pesticides, may inhibit Antol's metabolism, leading to decreased clearance and potentially increased systemic exposure of Antol itself. The use of alcohol may increase effects such as drowsiness and dizziness. Furthermore, Antol-induced dry mouth may prevent the dissolution of sublingual preparations, resulting in reduced effectiveness.

Interaction Restrictions

Co-use with Monoamine Oxidase Inhibitors (MAOIs) is generally not recommended in certain formulations due to the potential for hypertensive crisis. Interaction effects are officially noted as being more clinically significant in elderly or debilitated patients.

Mechanism of Action

The mechanism of action of Antol (Atropine Sulfate) is based on the competitive, non-selective blockade of all muscarinic acetylcholine receptors (M1 through M5). By preventing the binding of the natural neurotransmitter acetylcholine, Antol dampens the entire signaling cascade of the parasympathetic nervous system (parasympatholysis). This action leads to specific physiological consequences across multiple organ systems.

Modulation of Cardiac Vagal Tone

This domain covers the mechanism's influence on the heart, where the drug blocks the M2 receptors on the Sinoatrial (SA) node. The resulting interruption of the Vagus nerve's inhibitory signal leads to an acceleration of the heart's natural pacemaker rhythm and increased conduction velocity.

Inhibition of Glandular and Smooth Muscle Activity

This domain addresses the action of Antol on M3 receptors across exocrine glands and smooth muscle tissues. The mechanism suppresses the signal for fluid release, causing inhibition of output from exocrine glands (salivary, sweat, bronchial). Simultaneously, this blockade results in decreased tone and relaxation of involuntary smooth muscle in the intestines and airways.

Dosage and Administration Information

How Antol (Atropine Sulfate) is Used

The administration of Antol, which contains Atropine Sulfate, follows distinct guidelines determined by the required route: systemic for acute conditions or topical for local eye treatment. All usage principles are based on established clinical protocols, focusing on administration technique and standard dosing schedules.


Standard Routes and Dose Schedules

Administration Type Routes and Forms Standard Dosing Principles
Systemic (Acute Care) Intravenous (IV), Intramuscular (IM), Subcutaneous (SC) Injection Solution Bradycardia: 0.5 mg to 1 mg IV, repeated every 3 to 5 minutes. Total cumulative dose is often limited to 3 mg or 0.03 mg/kg in certain patients.
Local (Ocular) Topical Ophthalmic Solution or Ointment Ocular Use: Instill 1 to 2 drops of the 1% solution, up to 4 times daily for inflammatory conditions.

Administration and Timing Protocols

Systemic dosing is titratable and short-term, continuing only until a specific clinical end-point is achieved, often over a period of 24 to 48 hours in acute poisoning scenarios. Conversely, the local ocular effects are long-acting, with full mydriasis persisting for up to 1 to 2 weeks.

Established instructions include specific procedural steps for administration. For injectable solutions, the product must be visually inspected for particulate matter before use. For topical administration, standard practice includes performing nasolacrimal occlusion immediately after instillation. This step is a procedural requirement intended to reduce the drug's systemic absorption. Pediatric and older adult dosing begins at the low end of the range or is calculated on a weight-basis respectively.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Antol

Evidence for use in Type 2 Diabetes Mellitus

Research related to Antol in adults with Type 2 Diabetes Mellitus (T2DM) has focused primarily on randomized controlled trials (RCTs). RCTs was studied for periods ranging from a few weeks up to two years and evaluated in populations of adults with T2DM. These trials monitored several key outcomes related to systemic or functional imbalance, specifically focusing on measurements of HbA1c (a measure of average blood sugar over time) and blood glucose levels. Research also examined body weight changes and the frequency of adverse events was observed in the study populations.

Findings describe patterns observed in the studies related to measurements of HbA1c and glucose levels. The data show patterns related to how these levels were measured in the observed populations during the study period. It is important to remember that these findings describe group patterns and not individual predictions, and the results apply only to the populations studied.

Evidence for use in Chronic Weight Management

Research exploring Antol for chronic weight management has primarily relied on large Phase 3 randomized controlled trials. These studies was evaluated in adults who were classified as having obesity or who were overweight with weight-related health conditions. The research examined outcomes related to physical discomfort and functional limitations, specifically focusing on the percentage of total body weight change from the start of the study.

Studies report how body weight measurements evolved in the observed populations over study periods that often lasted for approximately 68 weeks. Studies report the percentage of participants whose measurements aligned with pre-defined weight change thresholds. Research contributes to understanding short-term body weight measurements. However, the study results reflect the specific conditions under which they were conducted, and findings describe group patterns, not personal outcomes.

What is Still Uncertain About Antol

This overview of research highlights that while Antol was studied for its effects on blood sugar control and body weight, the evidence is limited in several important areas. Long-term effects are not fully established, particularly regarding major health outcomes over many years. Follow-up durations were limited in many of the core trials. Furthermore, comparative evidence is lacking against all available treatment options, and data for specific groups, such as children or very older adults, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Antol (FAQ)


Q: What is the main reason doctors prescribe Antol?

According to official prescribing information, Antol (Atropine) is indicated for a few specific conditions. These primary uses include stabilizing a slow heart rate (bradycardia), serving as an antidote for certain poisonings, and for specific applications in ophthalmology to dilate the pupil (mydriasis) for eye exams or treatment.

Q: Is Antol the same type of medicine as [similar common drug name]?

Regulatory documents classify Antol (Atropine Sulfate) as an anticholinergic or antimuscarinic agent. This means the medicine works by blocking the action of a natural chemical messenger, acetylcholine, at nerve receptors in the body.

Q: How quickly can someone expect Antol to start working?

For the systemic injection form, effects on heart rate typically begin very quickly, often within a minute of intravenous administration. For the ophthalmic (eye) solution, the full pupil dilation effect is long-lasting and can persist for up to two weeks.

Q: What happens if I forget to take a dose of Antol?

Official patient information describes the protocol for a missed dose of forms used outside of acute care. The protocol generally involves a statement to take the dose as soon as it is remembered, unless it is close to the next scheduled time. The label usually states that a double dose should not be taken to compensate for the missed one.

Q: Are the side effects of Antol usually mild or severe?

Official labeling categorizes side effects into two groups. Common effects are related to the drug's anticholinergic properties and include things like dry mouth, blurred vision, and constipation. Less frequent but serious adverse reactions, such as acute glaucoma or severe cardiac rhythm disturbances, are also highlighted in the warnings section.

Q: Does taking Antol affect my ability to drive or operate machinery?

Official patient counseling information describes that Antol is associated with certain adverse effects—such as blurred vision, light sensitivity (photophobia), and confusion—that may impair the ability to safely drive or operate complex machinery.

Q: Is it common for people to feel nauseous after starting Antol?

Nausea, vomiting, and abdominal pain are listed in the official drug label as adverse reactions that have been reported with the use of Antol.

Q: Is Antol considered a high-risk medication?

The official labeling does not use the specific term 'high-risk,' but it does include several detailed Warnings and Precautions related to serious potential events. These risks, which include cardiovascular issues, acute glaucoma, and heat injury, mean the drug requires careful oversight and monitoring by a healthcare professional.

Q: Can older adults safely use Antol?

Official documents note that older adults may be more sensitive to the drug’s effects, particularly Central Nervous System (CNS) side effects such as confusion and memory impairment. Due to this increased sensitivity, official protocols generally require that dosing in this population begin at the low end of the allowed range.

Q: How long does Antol stay in the body after the last dose?

Pharmacokinetic data indicates the time it takes for half of the drug to leave the body (the half-life) is generally reported to be between two and four hours. It is noted that the elimination of the drug can vary, and its local ocular effects may persist for a much longer period.

Q: What is the typical course of treatment length for Antol?

For acute systemic conditions (e.g., severe poisoning), treatment is often short-term, continuing only until the patient is stable, which may be 24 to 48 hours or more. The length of use for ophthalmic or other non-acute systemic conditions can vary.

Q: Are there any specific foods or drinks that should be avoided when taking Antol?

Official regulatory documents describe that the use of alcohol is associated with an increased potential for side effects such as drowsiness and dizziness. There are no widespread regulatory warnings regarding specific foods, such as grapefruit, noted in the product information.

Q: Can Antol cause changes in mood or behavior?

Official product information notes that Antol can cause Central Nervous System (CNS) effects that include confusion, altered mental status, and mental aberrations, such as hallucinations. These effects are reported, especially with higher doses or in sensitive patient populations.

Q: How long does it take for the full effects of Antol to be reached?

Following injection, changes in heart rate are usually observed very quickly. Official studies indicate that significant levels of the drug may be achieved in the central nervous system within 30 minutes to one hour. The time it takes to reach the full therapeutic effect depends on the specific condition being treated.

Q: Can I take Antol if I have a history of heart issues?

Regulatory documents state that Antol is contraindicated (prohibited from use) in patients with uncompensated heart failure. The label also notes that the presence of pre-existing heart disease, recent heart attack, or certain heart rhythm issues is associated with a risk of worsening these conditions.

Q: What is the official safety classification of Antol?

Antol (Atropine) is generally not classified as a Controlled Substance for its standard formulations. Its use in pregnancy is associated with risks, and regulatory documents recommend it only be administered if clearly needed in emergency situations. It is fundamentally classified as an anticholinergic agent.

Q: Can taking Antol affect blood test results?

Regulatory patient information sometimes notes that healthcare providers may recommend blood or urine tests to check for unwanted effects while taking the medication. However, official labeling does not typically highlight a generalized interference with common blood test results.

Q: Is it normal to feel tired during the first few days of taking Antol?

The drug label lists fatigue or unusual drowsiness as potential effects, particularly in cases of overexposure or when doses are higher than normal. It is not generally listed as one of the most commonly reported side effects in standard use.

Q: Does Antol come with a patient medication guide?

Yes, official regulatory labeling and patient counseling information refer to the existence of an FDA-approved patient labeling or Patient Medication Guide that provides key information about the drug's use, warnings, and safe handling.

Q: What are the general expectations for using Antol?

General expectations are tied to the drug's official purpose, which is to block certain involuntary nerve signals. Depending on the condition, the expected outcome is an increase in heart rate (for bradycardia), the reversal of certain toxic effects (for poisoning), or pupil dilation (for eye examination purposes).

Q: Are there specific instructions for what to do in case of an overdose of Antol?

Yes, official regulatory documents provide guidance for overdosage. This includes descriptions of the symptoms of toxicity and notes that specific pharmacological treatments are available to manage effects such as severe excitement or convulsions.

Q: How do doctors monitor the effectiveness of Antol?

Official guidelines indicate that monitoring is focused on the drug's therapeutic target. For systemic uses, this involves observing the patient's heart rate, PR interval, blood pressure, and mental status for systemic use, or observing pupil size for ocular use.

Q: What is the difference between Antol and a supplement?

Antol (Atropine Sulfate) is an FDA/EMA-approved prescription drug, which means it has undergone a rigorous regulatory review process for safety and efficacy and requires a prescription. This differs from a dietary supplement, which is regulated under a separate set of governmental standards.

Q: Do studies suggest Antol is addictive?

Antol (Atropine Sulfate) is not typically classified as a controlled substance by regulatory agencies in the United States or other governmental bodies. This classification indicates that there is no official regulatory basis suggesting a significant risk of dependency or addiction.

Q: Is it possible to develop a tolerance to Antol over time?

Official clinical pharmacology reviews note that in cases of severe poisoning, patients may develop what is called tolerance to the drug. This means higher or more frequent doses may be required by the clinician to maintain therapeutic effects.

How should Antol be stored and disposed of?

Storage

To maintain the quality and effectiveness of Antol, store the medication in its original container, securely closed. Keep Antol at room temperature, away from excessive heat, moisture, and direct light, unless otherwise directed by the package labeling or your pharmacist. A location out of the reach and sight of children and pets is essential to prevent accidental ingestion or misuse. Do not store this medicine in the bathroom or near a kitchen sink due to humidity variations.

Disposal

Expired or unneeded Antol should be disposed of promptly and safely. The most preferred method is to utilize a community drug take-back program or a disposal kiosk often available at pharmacies and police departments. If a take-back option is not immediately available, and the drug is not on a specific flush list, it may typically be discarded in the household trash. To prepare for trash disposal, mix the medication with an undesirable substance, such as used coffee grounds or cat litter, place the mixture in a sealed container or bag, and then discard it. Remove or scratch out all personal information on the prescription label before disposing of the empty container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antol found in:

A-Z Index: